Literature DB >> 3980264

The role of radiation therapy in the management of intracranial meningiomas.

M J Solan, S Kramer.   

Abstract

Thirty-two patients with the diagnosis of intracranial meningioma were treated with radiation therapy over the past 24 years at the Thomas Jefferson University Hospital. Indications for irradiation included incomplete resection, malignant histology, and progressive or recurrent disease after curative surgery. Patients with malignant histology did poorly, with only 2 of 7 alive. This contrasts with 17 of 25 patients with benign histology who are either alive and well or who have enjoyed a long-term disease-free survival. No difference in ultimate outcome could be found between patients with benign histology irradiated in the immediate postoperative period as opposed to those irradiated at time of progression or recurrence.

Entities:  

Mesh:

Year:  1985        PMID: 3980264     DOI: 10.1016/0360-3016(85)90297-4

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  9 in total

1.  Efficacy of conventional radiotherapy for recurrent meningioma.

Authors:  M Kokubo; Y Shibamoto; J A Takahashi; K Sasai; N Oya; N Hashimoto; M Hiraoka
Journal:  J Neurooncol       Date:  2000-05       Impact factor: 4.130

2.  Atypical and anaplastic meningiomas--does the new WHO-classification of brain tumours affect the indication for postoperative irradiation?

Authors:  W Hoffmann; H Mühleisen; C F Hess; R D Kortmann; B Schmidt; E H Grote; M Bamberg
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

3.  Management of atypical and malignant meningiomas: role of high-dose, 3D-conformal radiation therapy.

Authors:  E B Hug; A Devries; A F Thornton; J E Munzenride; F S Pardo; E T Hedley-Whyte; M R Bussiere; R Ojemann
Journal:  J Neurooncol       Date:  2000-06       Impact factor: 4.130

4.  Malignant meningioma: an indication for initial aggressive surgery and adjuvant radiotherapy.

Authors:  T W Dziuk; S Woo; E B Butler; J Thornby; R Grossman; W S Dennis; H Lu; L S Carpenter; J K Chiu
Journal:  J Neurooncol       Date:  1998-04       Impact factor: 4.130

5.  [The role of radiotherapy in the treatment of malignant meningiomas].

Authors:  A DeVries; J E Munzenrider; T Hedley-Whyte; E B Hug
Journal:  Strahlenther Onkol       Date:  1999-02       Impact factor: 3.621

6.  Inhibition of angiogenesis and growth of human non-malignant and malignant meningiomas by TNP-470.

Authors:  T Yazaki; Y Takamiya; P C Costello; T Mineta; A G Menon; S D Rabkin; R L Martuza
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

7.  Intracranial meningiomas. Analysis of 344 surgically treated cases.

Authors:  N Altinörs; L Gürses; N Arda; A Türker; E Senveli; T Dönmez; M Sanli; M Bavbek; H Caner
Journal:  Neurosurg Rev       Date:  1998       Impact factor: 3.042

8.  TGF alpha expression in meningioma--tumor progression and therapeutic response.

Authors:  R M Linggood; D W Hsu; J T Efird; F S Pardo
Journal:  J Neurooncol       Date:  1995-10       Impact factor: 4.130

9.  The role of radiotherapy in the treatment of subtotally resected benign meningiomas.

Authors:  R Miralbell; R M Linggood; S de la Monte; K Convery; J E Munzenrider; R O Mirimanoff
Journal:  J Neurooncol       Date:  1992-06       Impact factor: 4.130

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.